VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $949,945 (100.0% shares, 0.0% debt)

Holdings (37)

APGE APOGEE THERAPEUTICS INC 19.0%
Value ($000) $180,908 Shares 8,493,321 Est. Cost $22.03 Unrealized 0.0%
RAYZEBIO INC 9.4%
Value ($000) $89,174 Shares 4,016,847 Est. Cost $22.20 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 5.0%
Value ($000) $47,287 Shares 3,082,622 Est. Cost $20.23 Unrealized -5.7%
COGT COGENT BIOSCIENCES INC 4.8%
Value ($000) $45,671 Shares 4,684,167 Est. Cost $8.79 Unrealized +35.0%
TSHA TAYSHA GENE THERAPIES INC 4.8%
Value ($000) $45,644 Shares 14,444,444 Est. Cost $1.87 Unrealized 0.0%
MERUS N V 4.3%
Value ($000) $40,704 Shares 1,726,214 Est. Cost $18.62 Unrealized
ELVN ENLIVEN THERAPEUTICS INC 4.2%
Value ($000) $40,364 Shares 2,954,902 Est. Cost $19.48 Unrealized -13.6%
FDMT 4D MOLECULAR THERAPEUTICS IN 4.0%
Value ($000) $38,190 Shares 3,000,000 Est. Cost $18.41 Unrealized -9.2%
PHVS PHARVARIS N V 3.4%
Value ($000) $32,631 Shares 1,563,513 Est. Cost $10.96 Unrealized +68.2%
CABA CABALETTA BIO INC 3.2%
Value ($000) $30,033 Shares 1,973,253 Est. Cost $3.87 Unrealized +253.4%
KALV KALVISTA PHARMACEUTICALS INC 3.0%
Value ($000) $28,088 Shares 2,916,667 Est. Cost $5.36 Unrealized +90.7%
GHRS GH RESEARCH PLC 2.9%
Value ($000) $27,578 Shares 2,744,125 Est. Cost $17.34 Unrealized -33.3%
HILLEVAX INC 2.9%
Value ($000) $27,402 Shares 2,037,313 Est. Cost $13.45 Unrealized
SVRA SAVARA INC 2.9%
Value ($000) $27,159 Shares 7,184,865 Est. Cost $1.58 Unrealized +125.8%
RYTM RHYTHM PHARMACEUTICALS INC 2.6%
Value ($000) $24,988 Shares 1,090,000 Est. Cost $18.05 Unrealized +24.1%
AMBRX BIOPHARMA INC 2.5%
Value ($000) $23,805 Shares 2,070,000 Est. Cost $8.92 Unrealized
TVTX TRAVERE THERAPEUTICS INC 2.5%
Value ($000) $23,456 Shares 2,623,677 Est. Cost $14.11 Unrealized 0.0%
DYN DYNE THERAPEUTICS INC 2.1%
Value ($000) $19,478 Shares 2,173,913 Est. Cost $11.80 Unrealized -8.7%
CELC CELCUITY INC 2.0%
Value ($000) $19,243 Shares 2,105,386 Est. Cost $10.24 Unrealized -3.9%
TERN TERNS PHARMACEUTICALS INC 1.6%
Value ($000) $15,554 Shares 3,092,273 Est. Cost $3.82 Unrealized +66.2%
MERSANA THERAPEUTICS INC 1.5%
Value ($000) $14,387 Shares 11,328,000 Est. Cost $1.27 Unrealized
APPLIED THERAPEUTICS INC 1.5%
Value ($000) $14,089 Shares 5,658,034 Est. Cost $1.28 Unrealized
ORIC ORIC PHARMACEUTICALS INC 1.4%
Value ($000) $12,964 Shares 2,142,856 Est. Cost $5.68 Unrealized +44.3%
DNTH DIANTHUS THERAPEUTICS INC 1.3%
Value ($000) $12,682 Shares 927,706 Est. Cost $12.62 Unrealized 0.0%
ADVERUM BIOTECHNOLOGIES INC 1.0%
Value ($000) $9,860 Shares 6,573,300 Est. Cost $1.55 Unrealized
PRAXIS PRECISION MEDICINES I 1.0%
Value ($000) $9,071 Shares 5,304,410 Est. Cost $1.15 Unrealized
ACELYRIN INC 0.9%
Value ($000) $8,790 Shares 864,332 Est. Cost $10.17 Unrealized
TRVI TREVI THERAPEUTICS INC 0.8%
Value ($000) $7,461 Shares 3,422,397 Est. Cost $2.46 Unrealized -8.3%
ACRS ACLARIS THERAPEUTICS INC 0.8%
Value ($000) $7,129 Shares 1,040,754 Est. Cost $13.57 Unrealized -37.0%
MIST MILESTONE PHARMACEUTICALS IN 0.7%
Value ($000) $6,847 Shares 2,208,812 Est. Cost $7.58 Unrealized -59.0%
PLRX PLIANT THERAPEUTICS INC 0.5%
Value ($000) $5,010 Shares 288,949 Est. Cost $21.42 Unrealized -19.1%
SGMT SAGIMET BIOSCIENCES INC 0.5%
Value ($000) $4,532 Shares 515,000 Est. Cost $13.31 Unrealized 0.0%
AEGLEA BIOTHERAPEUTICS INC 0.4%
Value ($000) $3,614 Shares 295,034 Est. Cost $0.45 Unrealized
LYRA THERAPEUTICS INC 0.4%
Value ($000) $3,614 Shares 924,170 Est. Cost $5.65 Unrealized
OLMA OLEMA PHARMACEUTICALS INC 0.1%
Value ($000) $951 Shares 77,042 Est. Cost $10.19 Unrealized 0.0%
RALLYBIO CORP 0.1%
Value ($000) $905 Shares 268,532 Est. Cost $7.55 Unrealized
AFFIMED N V 0.1%
Value ($000) $683 Shares 1,428,571 Est. Cost $5.52 Unrealized